Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7230422 | 0.85 | PTGS1 (0.47) | PTGS2 | |
| SCHEMBL7228934 | 0.80 | PTGS2 (0.46) | PTGS2 | |
| SCHEMBL6344383 | 0.80 | PTGS2 (0.56) | PTGS2 | |
| SCHEMBL7042172 | 0.79 | PTGS1 (0.45) | PTGS2 | |
| SCHEMBL7045200 | 0.79 | PTGS1 (0.48) | PTGS2 | |
| SCHEMBL6165295 | 0.73 | PTGS1 (0.47) | PTGS2 | |
| SCHEMBL8689037 | 0.72 | ACHE (0.41) | — | |
| SCHEMBL8735027 | 0.71 | PTGS2 (0.59) | PTGS2 | |
| SCHEMBL7041609 | 0.70 | PTGS1 (0.62) | PTGS2 | |
| SCHEMBL6410104 | 0.68 | PTGS2 (0.54) | PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6538009-B2 | Selective cyclooxygenase-2 (COX-2) inhibitors; for example, 1-(5-Methanesulfonyl-pyridin-2-yl)-7-methoxy-3-trifluoromethyl-4,5-dihydro -1H-benzo(g) indazole | PFIZER, INC. | 2003-03-25 | — | — | US | claimed |
| US-20020115856-A1 | Pyrazole derivatives as anti-inflammatory/analgesic agents | SAKYA SUBAS MAN (US) | 2002-08-22 | — | — | US | claimed |
| EP-1233959-B1 | HETEROCYCLO-ALKYLSULFONYL PYRAZOLE DERIVATIVES AS ANTI-INFLAMMATORY/ANALGESIC AGENTS | PFIZER PROD INC (US) | 2005-03-16 | — | — | EP | disclosed |
| US-20030236258-A1 | Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents | PFIZER INC. | 2003-12-25 | — | — | US | disclosed |
| US-6538009-B2 | Selective cyclooxygenase-2 (COX-2) inhibitors; for example, 1-(5-Methanesulfonyl-pyridin-2-yl)-7-methoxy-3-trifluoromethyl-4,5-dihydro -1H-benzo(g) indazole | PFIZER, INC. | 2003-03-25 | — | — | US | disclosed |
| US-6531492-B1 | Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents | PFIZER INC. | 2003-03-11 | — | — | US | disclosed |
| US-20020115856-A1 | Pyrazole derivatives as anti-inflammatory/analgesic agents | SAKYA SUBAS MAN (US) | 2002-08-22 | — | — | US | disclosed |
| EP-1142889-A1 | Pyrazole derivatives as anti-inflammatory/analgesic agents | Pfizer Products Inc. (US) | 2001-10-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030236258-A1 | Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents | PTGS1, SULT2A1, PTGES3 | PTGS2 4/4885 |
| US-20020115856-A1 | Pyrazole derivatives as anti-inflammatory/analgesic agents | FPR3, P2RX3, FPR1 | PTGS2 72/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.